Cargando…
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study
[Image: see text] Arsenoplatin-1 (AP-1) is a dual-action anticancer metallodrug with a promising pharmacological profile that features the simultaneous presence of a cisplatin-like center and an arsenite center. We investigated its interactions with proteins through a joint experimental and theoreti...
Autores principales: | Tolbatov, Iogann, Cirri, Damiano, Tarchi, Matteo, Marzo, Tiziano, Coletti, Cecilia, Marrone, Alessandro, Messori, Luigi, Re, Nazzareno, Massai, Lara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864615/ https://www.ncbi.nlm.nih.gov/pubmed/35137586 http://dx.doi.org/10.1021/acs.inorgchem.1c03732 |
Ejemplares similares
-
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt(3))I: A Theoretical and Experimental Study
por: Tolbatov, Iogann, et al.
Publicado: (2020) -
Reactivity of Gold(I) Monocarbene Complexes with Protein Targets: A Theoretical Study
por: Tolbatov, Iogann, et al.
Publicado: (2019) -
Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity
por: Ferraro, Giarita, et al.
Publicado: (2021) -
Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey
por: Tolbatov, Iogann, et al.
Publicado: (2021) -
In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
por: Cirri, Damiano, et al.
Publicado: (2021)